| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871369 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
Among patients with surgically treated staphylococcal IE there was insufficient evidence to claim a reoperation-free survival benefit from treatment with rifampin. Rifampin should not be used as adjunctive therapy for staphylococcal IE in patients who have undergone surgical procedures for its treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nabin K. Shrestha, Shailee Y. Shah, Hannah Wang, Syed T. Hussain, Gosta B. Pettersson, Amy S. Nowacki, Steven M. Gordon,